47
OrbiMed Asia Partners VI closes $1.05B institutional private equity fund
Fund raise update · Private equity / buyout · Closed · Offering $1.05B · Sold $1.05B · NEW YORK, NY · filed 2026-10-16
3(c)(7) — qualified purchasers
100
OrbiMed Asia Partners VI, L.P. files a $850M private equity / buyout fund
New fund · Private equity / buyout · Pre-first close · NEW YORK, NY · Form D filed 2025-09-29 · all Orbimed Asia vehicles
3(c)(7) — qualified purchasersPre-first closeFirst filing by this entityrepeat_fund_numeralPlacement agent engaged
Why now — by persona
Relevant to: Fund administrator, Fund audit & tax, Fund-formation counsel, Compliance consultant / RIA registration. Lead card pending.
People on the filing
| David G. Wang | Director of the GPLTD |
| Sunny Carter Sharma | Director of the GPLTD |
| Sven H. Borho | Director of the GPLTD |
| W. Carter Neild | Director of the GPLTD |
| N/A OrbiMed Asia GP VI, L.P. | "General Partner of the Issuer (the ""GPLP"")" |
| Carl L. Gordon | Director of the GPLTD |
| N/A OrbiMed Advisors VI Limited | "General Partner of the GPLP (the ""GPLTD"")" |
Signed by W. Carter Neild, Director of the GPLTD.
Placement agents / sales compensation: UBS Switzerland AG; UBS Financial Services Inc.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
47
OrbiMed Asia Partners VI, L.P. updates its Form D — $534M sold
Fund raise update · Private equity / buyout · Raising · Offering $850M · Sold $534M · NEW YORK, NY · filed 2026-05-28
3(c)(7) — qualified purchasers